Product Program year 2025 Source: CMS Open Payments

Visudyne

Drug Ophthalmology

NDC 0187-5600-15

Open in the dashboard

General payments

$5,353,928

1,649 payments

Research payments

$512,914

5 payments

Through program year 2025, $5,353,928 in general payments and $512,914 in research payments were reported against Visudyne (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

12 rows
Year Kind Amount Payments
2025 General $630,867 138
2024 General $796,859 190
2023 General $618,637 282
2023 Research $128,228 1
2022 General $30,024 243
2022 Research $170,971 1
2021 General $642,025 243
2021 Research $102,583 1
2020 General $1,083,329 206
2020 Research $102,583 1
2019 General $1,552,187 347
2019 Research $8,549 1

Breakdown

Who paid General payments · program years 2019–2025
  1. Bausch & Lomb, a division of Bausch Health US, LLC $3,277,416 795 payments
  2. Bausch & Lomb Americas Inc. $2,076,387 853 payments
  3. Solta Medical, a division of Bausch Health US, LLC $125 1 payment
Top recipients General payments · program year 2025
  1. Massachusetts Eye And Ear Infirmary Teaching hospital · MA $625,440 99% · 4 payments
  2. Ramon Lee Retina Specialist · Royal Oak, MI $2,000 <1% · 1 payment
  3. Jordana Fein Retina Specialist · Manassas, VA $500 <1% · 1 payment
  4. Gregg Kokame Ophthalmology · Aiea, HI $70 <1% · 1 payment
  5. Elysse Tom Ophthalmology · Honolulu, HI $70 <1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Retina Specialist Ophthalmology $3,691 68% · 48 practitioners
  2. Ophthalmology $1,582 29% · 61 practitioners
  3. Optometrist $98 2% · 4 practitioners
  4. Pediatric Emergency Medicine Pediatrics $16 <1% · 1 practitioner
  5. Obstetrics & Gynecology $16 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Massachusetts $625,440 99% · 1 recipient
  2. Illinois $2,035 <1% · 3 recipients
  3. Virginia $643 <1% · 7 recipients
  4. Texas $355 <1% · 13 recipients
  5. North Carolina $325 <1% · 15 recipients

The top 5 of 26 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Given in the clinic

Part B · billing code
Medicare Part B billing codes matched to VISUDYNE
Billing code Providers Services Paid by Medicare
Injection, verteporfin, 0.1 mg J3396 4 15,536 $140,138

Drugs given by a clinician are billed to Medicare Part B, not Part D. The product is tied to a billing code through the NDC on CMS's crosswalk, which was published for a later quarter than the payments, so a code that changed in between can be missed. Providers with fewer than 11 patients for the code are not published. Medicare's payment here is what it paid for the services, to the billing practice.

1,649 general · 5 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record